Dysregulation of protein phosphorylation/dephosphorylation in Alzheimer's disease: a therapeutic target
about
Is protein phosphatase inhibition responsible for the toxic effects of okadaic Acid in animals?Okadaic acid induces tau phosphorylation in SH-SY5Y cells in an estrogen-preventable mannerCombinatorial Tau pseudophosphorylation: markedly different regulatory effects on microtubule assembly and dynamic instability than the sum of the individual partsQuantitative proteomics analysis of phosphorylated proteins in the hippocampus of Alzheimer's disease subjects.Site-specific effects of tau phosphorylation on its microtubule assembly activity and self-aggregation.Overexpression of Dyrk1A contributes to neurofibrillary degeneration in Down syndrome.Microtubule-associated protein tau in bovine retinal photoreceptor rod outer segments: comparison with brain tauDevelopmental regulation of tau phosphorylation, tau kinases, and tau phosphatases.Physiological regulation of tau phosphorylation during hibernationDysregulation of insulin signaling, glucose transporters, O-GlcNAcylation, and phosphorylation of tau and neurofilaments in the brain: Implication for Alzheimer's disease.Abnormal mitochondrial dynamics--a novel therapeutic target for Alzheimer's disease?Tandem mass spectrometry strategies for phosphoproteome analysis.Alzheimer's disease, cholesterol, and statins: the junctions of important metabolic pathways.Protein Phosphorylation is a Key Mechanism in Alzheimer's Disease.Blockade of NR2A-containing NMDA receptors induces Tau phosphorylation in rat hippocampal slices.Alzheimer's disease, a multifactorial disorder seeking multitherapies.Fine mapping of calcineurin (PPP3CA) gene reveals novel alternative splicing patterns, association of 5'UTR trinucleotide repeat with addiction vulnerability, and differential isoform expression in Alzheimer's disease.Phosphoproteome profiling of substantia nigra and cortex regions of Alzheimer's disease patients.The Alzheimer's disease related tau protein as a new target for chemical protein engineering.
P2860
Q24630765-0DD856B6-BBA7-4EE3-B3C9-BE4D0D53EA92Q34035745-6A8B5AE3-A47E-417A-AEE5-7CAB5C1B8205Q34800214-C213024E-70FB-4E17-92A0-8212DE8EA176Q35059268-AB4CE637-81FE-49ED-824E-26B3E4C98BBEQ36487480-D805B7AB-FCB7-44BC-9E8C-1D7BF6C47678Q36841753-750FB40B-AE5D-4838-894E-8D599638FF50Q37047815-7A61E32B-88A2-492C-A8DC-2400E7233FAEQ37177555-3141AA21-6304-4A65-A94A-9784F6AA793DQ37229319-23A4BB6C-C8FA-4CD7-ACAD-60AF961232ABQ37413705-CA05513A-A01E-4F42-9F79-1623A693BC1CQ37681370-43248085-5E2C-4116-9262-F632BFCB0F77Q37835773-EBB2D608-34A1-40CD-BB69-14A82A75EDDEQ38071004-E22476D8-4C10-4862-A69F-804976CDA68BQ39319453-1E66BCEC-9B9D-4371-9E40-B8FE6BA41CC8Q40700702-70FBAB2B-B8BF-46D0-BC51-E839FEED4D8DQ42418656-F0597776-DFC3-493A-B903-68BAEDF68700Q42585953-0CBA1C9F-6F9F-4325-97C6-675A4F7A0F93Q48604330-385E1C20-2B7B-4F41-B777-B9B2E623F387Q52890311-D6E6A98A-2FA2-437C-850E-63E1A06720D0
P2860
Dysregulation of protein phosphorylation/dephosphorylation in Alzheimer's disease: a therapeutic target
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Dysregulation of protein phosp ...... disease: a therapeutic target
@ast
Dysregulation of protein phosp ...... disease: a therapeutic target
@en
type
label
Dysregulation of protein phosp ...... disease: a therapeutic target
@ast
Dysregulation of protein phosp ...... disease: a therapeutic target
@en
prefLabel
Dysregulation of protein phosp ...... disease: a therapeutic target
@ast
Dysregulation of protein phosp ...... disease: a therapeutic target
@en
P2860
P356
P1476
Dysregulation of protein phosp ...... disease: a therapeutic target
@en
P2093
P2860
P356
10.1155/JBB/2006/31825
P577
2006-01-01T00:00:00Z